Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Advanced Drug Delivery Reviews
|
December 6, 2014
Tissue engineering in urothelium regeneration
Martin Vaegler, Sabine Maurer, Patricia Toomey, et al.
European Urology
|
February 19, 2008
In vitro investigations of tissue-engineered multilayered urothelium established from bladder washings
Udo Nagele, Sabine Maurer, Gerhard Feil, et al.
European Urology
|
November 6, 2007
Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue
Gerhard Feil, Sabine Maurer, Udo Nagele, et al.
Advanced Drug Delivery Reviews
|
December 21, 2010
From tissue engineering to regenerative medicine in urology--the potential and the pitfalls
Gerhard Feil, Lisa Daum, Bastian Amend, et al.
Anticancer Research
|
June 25, 2003
Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder
Gerhard Feil, Andreas Zumbrägel, Hans J Päulgen-Nelde, et al.
World Journal of Urology
|
October 27, 2016
Collagen cell carriers seeded with human urothelial cells for urethral reconstructive surgery: first results in a xenograft minipig model
Stefan Aufderklamm, Martin Vaegler, Alexandra Kelp, et al.
European Urology
|
July 6, 2006
Investigations of urothelial cells seeded on commercially available small intestine submucosa
Gerhard Feil, Margot Christ-Adler, Sabine Maurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 10, 2019
Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation
Sabine Maurer, Peter Herhaus, Romina Lippenmeyer, et al.
JCI Insight
|
August 9, 2019
Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma
Anna K Scherger, Mona Al-Maarri, H. Carlo Maurer, et al.
Scientific Reports
|
February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy
Kathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Advanced Drug Delivery Reviews
|
December 6, 2014
Tissue engineering in urothelium regeneration
Martin Vaegler, Sabine Maurer, Patricia Toomey, et al.
European Urology
|
February 19, 2008
In vitro investigations of tissue-engineered multilayered urothelium established from bladder washings
Udo Nagele, Sabine Maurer, Gerhard Feil, et al.
European Urology
|
November 6, 2007
Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue
Gerhard Feil, Sabine Maurer, Udo Nagele, et al.
Advanced Drug Delivery Reviews
|
December 21, 2010
From tissue engineering to regenerative medicine in urology--the potential and the pitfalls
Gerhard Feil, Lisa Daum, Bastian Amend, et al.
Anticancer Research
|
June 25, 2003
Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder
Gerhard Feil, Andreas Zumbrägel, Hans J Päulgen-Nelde, et al.
World Journal of Urology
|
October 27, 2016
Collagen cell carriers seeded with human urothelial cells for urethral reconstructive surgery: first results in a xenograft minipig model
Stefan Aufderklamm, Martin Vaegler, Alexandra Kelp, et al.
European Urology
|
July 6, 2006
Investigations of urothelial cells seeded on commercially available small intestine submucosa
Gerhard Feil, Margot Christ-Adler, Sabine Maurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 10, 2019
Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation
Sabine Maurer, Peter Herhaus, Romina Lippenmeyer, et al.
JCI Insight
|
August 9, 2019
Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma
Anna K Scherger, Mona Al-Maarri, H. Carlo Maurer, et al.
Scientific Reports
|
February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy
Kathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
Page
of 2